A Randomized Controlled Pilot Trial of Valacyclovir for Attenuating Inflammation and Immune Activation in HIV/Herpes Simplex Virus 2–Coinfected Adults on Suppressive Antiretroviral Therapy
Investigating how valacyclovir affects systemic immune activation or inflammatory biomarkers in HIV-1/HSV-2–coinfected adults on suppressive ART
View Publication